NOW ENROLLING

Phase III breast cancer trial

Patients with locally advanced or metastatic,
triple-negative or HR+/HER2- breast cancer

Learn about this Phase III breast cancer trial

IPATunity130
BioOncology Genentech

© 2018 Genentech USA, Inc. All rights reserved. BIO/013018/0009